» Articles » PMID: 9278511

Conservation of the Chk1 Checkpoint Pathway in Mammals: Linkage of DNA Damage to Cdk Regulation Through Cdc25

Overview
Journal Science
Specialty Science
Date 1997 Sep 5
PMID 9278511
Citations 429
Authors
Affiliations
Soon will be listed here.
Abstract

In response to DNA damage, mammalian cells prevent cell cycle progression through the control of critical cell cycle regulators. A human gene was identified that encodes the protein Chk1, a homolog of the Schizosaccharomyces pombe Chk1 protein kinase, which is required for the DNA damage checkpoint. Human Chk1 protein was modified in response to DNA damage. In vitro Chk1 bound to and phosphorylated the dual-specificity protein phosphatases Cdc25A, Cdc25B, and Cdc25C, which control cell cycle transitions by dephosphorylating cyclin-dependent kinases. Chk1 phosphorylates Cdc25C on serine-216. As shown in an accompanying paper by Peng et al. in this issue, serine-216 phosphorylation creates a binding site for 14-3-3 protein and inhibits function of the phosphatase. These results suggest a model whereby in response to DNA damage, Chk1 phosphorylates and inhibits Cdc25C, thus preventing activation of the Cdc2-cyclin B complex and mitotic entry.

Citing Articles

ATR safeguards replication forks against APOBEC3B-induced toxic PARP1 trapping.

Ortega P, Bournique E, Li J, Sanchez A, Santiago G, Harris B bioRxiv. 2024; .

PMID: 39605722 PMC: 11601322. DOI: 10.1101/2024.11.14.623607.


Exploiting spirooxindoles for dual DNA targeting/CDK2 inhibition and simultaneous mitigation of oxidative stress towards selective NSCLC therapy; synthesis, evaluation, and molecular modelling studies.

Islam M, Al-Jassas R, Al-Majid A, Haukka M, Nafie M, Abu-Serie M RSC Med Chem. 2024; 15(8):2937-2958.

PMID: 39149093 PMC: 11324055. DOI: 10.1039/d4md00337c.


Desmoplastic small round cell tumor: from genomics to targets, potential paths to future therapeutics.

Magrath J, Espinosa-Cotton M, Flinchum D, Sampath S, Cheung N, Lee S Front Cell Dev Biol. 2024; 12:1442488.

PMID: 39139449 PMC: 11319132. DOI: 10.3389/fcell.2024.1442488.


Cryo-EM structure of the CDK2-cyclin A-CDC25A complex.

Rowland R, Korolchuk S, Salamina M, Tatum N, Ault J, Hart S Nat Commun. 2024; 15(1):6807.

PMID: 39122719 PMC: 11316097. DOI: 10.1038/s41467-024-51135-w.


The type of DNA damage response after decitabine treatment depends on the level of DNMT activity.

Aumer T, Dather M, Bergmayr L, Kartika S, Zeng T, Ge Q Life Sci Alliance. 2024; 7(9).

PMID: 38906675 PMC: 11192838. DOI: 10.26508/lsa.202302437.